News
Pfizer Jab For Kids Under Five May Not Be Out Soon Says FDA
In a recent development, which is a kind of a setback in the case of inoculation for kids, the FDA has confirmed that it is going to delay authorising the use of the Pfizer vaccine in the younger lot...
News
WHO prequalifies first monoclonal antibody – tocilizumab – to treat COVID-19
Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, to its list of prequalified treatments for COVID-19. To date, six COVID-19 treatments have been prequalified by WHO, including the three presentations (three...
Drug Research
BioGenes, Alphalyse partner to optimize ELISA reagent characterization for biomanufacturing
BioGenes has partnered with Alphalyse, a specialist contract research organization. Recently, two companies that have been active in the field of Host Cell Protein (HCP) detection for many years have partnered up to offer their respective methods to biologics...
News
Pistoia Alliance launches Women in STEM leadership pilot to support members talent and diversity goals
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has today announced the launch of a new Women in STEM leadership pilot program. The program is aimed at organizations seeking to develop...
News
Plant Based Cure To Stop COVID And Effects And Also Omicron
Life Science Newswire – The startup company Novel Concepts Medical is delighted to announce another major breakthrough in its research of COVID-19.
Its novel plant-based treatment has resulted in successfully inhibiting the COVID-19 Omicron variant and blocking its connection to...
News
AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus
AiCuris Anti-infective Cures AG (AiCuris), a leading company in the discovery and development of drugs against infectious diseases, and Hybridize Therapeutics (Hybridize), focused on the development of RNA-based therapies for patients with acute and chronic kidney diseases, today announced...
Drug Research
Berkshire Sterile to offer formulation, lyophilization, and method development services
Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has recently added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions.
BSM will now offer first-in-human formulation development, supply material for preclinical studies,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















